Article
The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking.
Journal of lipid research - 1 Feb 2004
Zhang Jessie, Dudley-Rucker Nicole, Crowley Jan R, Lopez-Perez Elvira, Issandou Marc, Schaffer Jean E, Ory Daniel S
Abstract excerpt
Recently, a new class of lipid-lowering agents has been described that upregulate LDL receptor (LDLr) activity. These agents are proposed to activate sterol-regulated gene expression through binding to the sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP). Here, we show that the steroidal LDLr upregulator, GW707, induces accumulation of lysosomal free cholesterol and inhibits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
